Back to Evidence
Paper-scoped peptide mentionSequence reported

P12

PMC10126514::PEP000003

Source publication

The interaction of peptide inhibitors and Aβ protein: Binding mode analysis, inhibition of the formation of Aβ aggregates, and then exert neuroprotective effects.

Frontiers in Aging Neuroscience · 2023

Sequence status
reported
Standardization
Sequence ready
Source location
text
Activity records
3

Sequence evidence

Reported molecular identity

YVRHDLYVRHDL

P12(Ac-YVRHDLYVRHDL-NH2) was purchased from GL Biochem Ltd. (Shanghai).

Resolved peptide links

Experimental observations

Records linked to this mention

ToxicityCytotoxicNegative / threshold
Record detail

Figure 3C: P12 has significant effect on the viability of PC12 cells at 6.25 uM (p < 0.05). But there was no significant difference at other concentrations.

Measure
cell_viability
Value
significant effect at 6.25 uM (p<0.05), no significant difference at other concentrations
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
OtherAnti-AggregationPositive observation
Record detail

Figure 4: compared with the Aβ positive control group, the fluorescence intensity of P9 and P12 polypeptides has increased, but the difference is not statistically significant (p > 0.05), indicating that P9 and P12 have no inhibitory effect on Aβ aggregation.

Measure
percent_inhibition
Value
fluorescence intensity increased, no inhibitory effect (p>0.05)
Target
Aβ1-42
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.